This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
May 9-12, 2022 | In-Person + DigitalHynes Convention Center, Boston

Caitlyn Miller
Researcher at Stanford University


Caitlyn Miller’s research focuses on developing tumor-targeting immunostimulant conjugates to improve therapeutic index and enable systemic delivery for cancer immunotherapy. Caitlyn is co-advised by Carolyn Bertozzi and Jennifer Cochran at Stanford University, and she will receive her PhD in Bioengineering in March 2022.

Agenda Sessions

  • Delivering Immunotherapy to Tumors using an Engineered Peptide-Immunostimulant Conjugate